About Careers MedBlog Contact us

Common Cholesterol Drug may Stimulate Appetite, Relieve Pain, Prevent Depression

by Bidita Debnath on April 4, 2015 at 5:53 PM
Font : A-A+

Common Cholesterol Drug may Stimulate Appetite, Relieve Pain, Prevent Depression

A new research suggests that fenofibrate, a common drug used to control cholesterol levels in patients, activates the same receptors as cannabis and may become a viable treatment option for relieving pain, stimulating appetite, reducing nausea and preventing depression.

These are the benefits of medical marijuana without the "unwanted side effects" of cannabis. "By illustrating the relationship between fenofibrate and the cannabinoid system, we aim to improve our understanding of this clinically important drug," said Dr. Richard S. Priestley from the University of Nottingham, England.


According to the research report published in the FASEB Journal, fenofibrate may benefit a wide range of health issues, such as appetite stimulation, pain and nausea control, as well as immune and various psychiatric and neurological conditions. This suggests that fenofibrate may be the starting point for a new class of cannabis-like drugs to treat these types of conditions.

"Our study provides the basis for the investigation of new drugs targeting these important receptors," Priestley said.

To make this discovery, Priestly and colleagues cultured cells containing cannabinoid receptors and exposed them to a tracer compound, which binds to cannabinoid receptors. They found that fenofibrate was able to displace the tracer, suggesting that it also binds to the receptors.

Furthermore, they discovered that fenofibrate actually switched the cannabinoid receptors "on", not only in these cells, but also in sections of intestine. This led to the relaxation of the tissue in a way that mimicked what marijuana does.

Despite the fact that fenofibrate has been used for many years, and its mechanism of action was presumed to be through a completely different family of receptors, this suggests that at least some of the effects of fenofibrate may be controlled by cannabinoid receptors.

Furthermore, these cannabinoid receptors may be a future target for drugs used to treat pain and a variety of immune and psychiatric diseases.

Source: IANS


Recommended Reading

Latest Drug News

 Parkinson's Unmet Needs Creates Path for New Entrants into the Market
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
How Microrobots Could Help Treat Bladder Diseases?
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
How Can Multivitamin Supplements Slow Cognitive Aging?
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
 Ivosidenib Approved for Acute Myeloid Leukemia & Advanced Cholangiocarcinoma
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
Sacubitril/valsartan Unleashes Hope for Heart Failure Patients
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Common Cholesterol Drug may Stimulate Appetite, Relieve Pain, Prevent Depression Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests